Sentry HC Worm X DS

Manufacturer
Sergeant's Pet Care Products, Inc. | ABS Corporation
Effective date
2018-12-14
Label type
OTC ANIMAL DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-02 00:34:38

Label at a glance#

ProductSentry HC Worm X DS
Active ingredientPyrantel Pamoate
Label structure7 sections

Label contents#

Full prescribing information#

DESCRIPTION SECTION

Sentry®HC

WormX® DS

(pyrantel pamoate)

Canine Anthelmintic Suspension
ANADA #200-007, Approved by FDA

WormX DS is a suspension of pyrantel pamoate in a palatable butterscotch flavored vehicle. Each mL contains 4.54 mg of pyrantel base as pyrantel pamoate.

Pyrantel pamoate is a compound belonging to a family classified chemically as tetrahydropyrimidines. It is a yellow, water-insoluble crystalline salt of the tetrahydropyrimidine base and pamoic acid containing 34.7% base activity. The chemical structure and name are given below.

Chemical StructureChemical Structure

(E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-thienyl) vinyl] pyrimidine 4,4' methylenebis [3-hydroxy-2-naphthoate](1:1)

INDICATIONS FOR USE:

INDICATIONS & USAGE SECTION

WormX DS suspension is a highly palatable formulation intended as a single treatment for the removal of large roundworms (Toxocara canis and Toxacaris leonina), and hookworms (Ancylostoma caninum and Uncinaria stenocephala) in dogs and puppies.

WormX DS suspension may also be used to prevent reinfestation of Toxocara canis in puppies and adult dogs and in lactating bitches after whelping.

Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism.

DOSAGE AND ADMINSITRATION:

DOSAGE & ADMINISTRATION SECTION

Administer one full teaspoon (5 mL) for each 10 pounds of body weight (2.27 mg base per lb. of body weight). Although most dogs have been observed to find this formulation very palatable and willingly consume it undiluted, it may be necessary to mix a small quantity of formulation in the dog's normal ration to encourage consumption. Fasting prior to and after treatment is not necessary.

For maximum control and prevention of reinfestation, it is recommended that puppies be treated at 2, 3, 4, 6, 8 and 10 weeks of age. Lactating bitches should be treated 2-3 weeks after whelping. Adult dogs kept in heavily contaminated quarters may be treated at monthly intervals to prevent T. canis reinfestation.

CAUTION: THIS PRODUCT IS A SUSPENSION AND AS SUCH WILL SEPARATE. TO ENSURE UNIFORM RESUSPENSION AND TO ACHIEVE PROPER DOSAGE, IT IS EXTREMELY IMPORTANT THAT THE PRODUCT BE SHAKEN THOROUGHLY BEFORE EVERY USE.

RECOMMENDED STORAGE: Store below 86°F (30°C).

SUMMARY OF SAFETY AND EFFECTIVENESS

EFFICACY

Critical (worm count) studies in dogs demonstrated that pyrantel pamoate at the recommended dosage is highly efficacious against T. leonina (99%), T. canis (85%), A. caninum (97%), and U. stenocephala (94%).

SAFETY

One of the most outstanding and significant features of pyrantel pamoate is its wide margin of therapeutic safety in dogs. The acute oral LD50 of pyrantel pamoate administered in gelatin capsules to female and male dogs is greater than 314 mg base per pound of body weight, which indicates a therapeutic index in excess of 138 X the recommended dosage. In subacute and chronic studies, no significant morphological abnormalities could be attributed to pyrantel pamoate when administered to dogs at daily dose rates up to 94 mg base per pound of body weight (40 x) for periods of 19, 30, and 90 days. Clinical studies conducted in a wide variety of geographic locations using more than 40 different breeds of dogs showed no drug-induced toxic effects. Included in these studies were nursing pups, weaned pups, adults, pregnant bitches and males at stud. Additional data have demonstrated the safe use of pyrantel pamoate in (1) dogs having heartworm infections and/or receiving medication for heartworms, (2) dogs exposed to organophosphate flea collars or flea/tick dip treatments, and (3) dogs undergoing concurrent treatment or medication at the time of worming such as immunization and antibacterial treatment.

SPL UNCLASSIFIED SECTION

If you have any questions or comments about this product, please write: SENTRY Consumer Response, PO Box 540399, Omaha, NE 68154-0399.

Distributed by:

Sergeant's Pet Care Products, Inc., Omaha, NE 68138

PRINCIPAL DISPLAY PANEL - 60 mL Bottle

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Sentry®HC

WormX® DS

(pyrantel pamoate)

FOR DOGS

Canine Anthelmintic Suspension

Active Ingredient:

4.54 mg of pyrantel base as pyrantel pamoate per mL

FOR ANIMAL USE  ONLY

ANADA #200-007 Approved by FDA

NET CONTENTS: 2 fl oz (60 mL)

60 mL bottle label60 mL bottle label

PRINCIPAL DISPLAY PANEL - 60 mL Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SENTRY®HC

WormX® DS

(pyrantel pamoate)

FOR DOGS

Canine Anthelmintic Suspension

• Removes Large Roundworms & Hookworms in puppies & dogs

• Treats dogs up to 120 lbs.

Active Ingredient: 4.54 mg of pyrantel base as pyrantel pamoate per mL

FOR ANIMAL USE ONLY

See back panel for complete use directions.

ANADA 200-007 Approved by FDA

NET CONTENTS: 2 fl oz (60 mL)

image of cartonimage of carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Pyrantel PamoateACTIVE INGREDIENT81BK194Z5M1
PyrantelACTIVE MOIETY4QIH0N49E71

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
21091-75021091-750-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 1 matching rows.

Name, UNII, Kind table
NameUNIIKind
Pyrantel Pamoate81BK194Z5MACTIM

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 16 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PINRIDPYRANTEL PAMOATEYYBA CORP59da86a4-db0d-4551-9128-e09a4e85cd782026-05-25WarningsName fallback
generic name: PYRANTEL PAMOATE
PINRIDPYRANTEL PAMOATEYYBA CORP52a9b5c8-08e6-b91e-e063-6294a90a0e0d2026-05-25WarningsName fallback
generic name: PYRANTEL PAMOATE
pinworm treatmentPYRANTEL PAMOATEBIONPHARMA INC.3cf96d04-e8bc-31af-e063-6294a90a0db82026-01-23WarningsName fallback
generic name: PYRANTEL PAMOATE
pinworm treatmentPYRANTEL PAMOATEAMERISOURCE BERGEN4837905f-1037-a319-e063-6294a90aba042026-01-21WarningsName fallback
generic name: PYRANTEL PAMOATE
Pyrantel PamoatePYRANTEL PAMOATEJefferson Labse862b337-2991-4b56-8584-fd80dccd725f2025-12-19WarningsName fallback
generic name: PYRANTEL PAMOATE
pinworm treatmentPYRANTEL PAMOATESTRATEGIC SOURCING SERVICES453c0645-f2b4-aa4a-e063-6294a90af1fb2025-12-05WarningsName fallback
generic name: PYRANTEL PAMOATE
LombrixPYRANTEL PAMOATEOPMX LLC3f940481-8e75-0bc7-e063-6394a90af1cd2025-09-24WarningsName fallback
generic name: PYRANTEL PAMOATE
PARASITOLPYRANTEL PAMOATEMenper Distributors Inc.cd5eb4c9-d0f0-4be7-84eb-88ebc4632dc62025-07-22WarningsName fallback
generic name: PYRANTEL PAMOATE
PINRIDPYRANTEL PAMOATEYYBA CORPfc225b5b-0ce8-4394-a643-39dbc674d7cd2025-07-02WarningsName fallback
generic name: PYRANTEL PAMOATE
MebendamaX PinwormPYRANTEL PAMOATEPharmadel LLC1d75b912-3550-7d4c-e063-6294a90ad5fa2025-06-18WarningsName fallback
generic name: PYRANTEL PAMOATE
Pyrantel PamoatePYRANTEL PAMOATEProMex LLCe68c503a-6f79-4f83-a6f3-c12a13fb06a02024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
Pinworm MedicinePYRANTEL PAMOATEREESE PHARMACEUTICAL CO.f23d5092-48ca-46c4-830a-c34d0a3a7f572024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
Walgreens Pinworm MedicinePYRANTEL PAMOATEWalgreens7fd58448-6846-4d8e-994c-d0ca2fd38e682024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
CVS Pinworm TreatmentPYRANTEL PAMOATECVS PHARMACY INCd079008a-c87a-45f2-8775-0e40241761f02024-12-18WarningsName fallback
generic name: PYRANTEL PAMOATE
VRMX 500PYRANTEL PAMOATEOPMX LLCe119cad8-9814-7d5a-e053-2995a90afde52024-02-06WarningsName fallback
generic name: PYRANTEL PAMOATE
Pyrantel PamoatePYRANTEL PAMOATEProMex LLCe68dd24a-93f8-4e2e-a698-d9ad9a7cebac2018-01-02WarningsName fallback
generic name: PYRANTEL PAMOATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.